Four‐year long‐term drug survival of dupilumab analyzed by treatment period in patients with moderate to severe atopic dermatitis: A real‐world retrospective study
Gespeichert in:
| Veröffentlicht in: | Journal of dermatology 2024-03, Vol.51 (3), p.e63-e65 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | e65 |
|---|---|
| container_issue | 3 |
| container_start_page | e63 |
| container_title | Journal of dermatology |
| container_volume | 51 |
| creator | Kang, Da‐Hyun Kwon, Soon‐Hyo Lew, Bark‐Lynn |
| description | |
| doi_str_mv | 10.1111/1346-8138.17017 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11483290</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2889243651</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4227-91ecb9b43d34b2988628a122a2802b23c16807945878dfcf27f72c40029626e73</originalsourceid><addsrcrecordid>eNqFkstu1DAUhiMEotPCmh2yxIZNWt8SO2xQVVouqsQG1pYTn0xdOXGwnRmFFY_Q1-C1eBI8TBkBG7yxffz5t8_5T1E8I_iU5HFGGK9LSZg8JQIT8aBYHSIPixVmsiopx-KoOI7xFmPaVAQ_Lo6YaCpcYbIqvl_5Ofz4dreADsj5cZ3XCcKATJjXKM5hYzfaId8jM0_WzYNukR61W76CQe2CUgCdBhgTmiBYb5Ad0aSTzZGItjbdoMEbCDoBSh5F2EAApJOfbIdyfMhosvEVOkdZyOXHtz44kzcp-DhBl-wGUEyzWZ4Uj3rtIjy9n0-Kz1eXny7eldcf376_OL8uO06pKBsCXdu0nBnGW9pIWVOpCaWaSkxbyjpSSywaXkkhTd_1VPSCdnxXm5rWINhJ8XqvO83tAKbLmQTt1BTsoMOivLbq75PR3qi13yhCuGS0wVnh5b1C8F9miEkNNnbgnB7Bz1FRKRvKWV2RjL74B73NfuT6ZqphnAhOcZWpsz3V5aLEAP3hNwSrXR-onetq57r61Qf5xvM_kzjwv43PQLUHttbB8j899eHN5V74J8igwyU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2934174205</pqid></control><display><type>article</type><title>Four‐year long‐term drug survival of dupilumab analyzed by treatment period in patients with moderate to severe atopic dermatitis: A real‐world retrospective study</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Kang, Da‐Hyun ; Kwon, Soon‐Hyo ; Lew, Bark‐Lynn</creator><creatorcontrib>Kang, Da‐Hyun ; Kwon, Soon‐Hyo ; Lew, Bark‐Lynn</creatorcontrib><identifier>ISSN: 0385-2407</identifier><identifier>ISSN: 1346-8138</identifier><identifier>EISSN: 1346-8138</identifier><identifier>DOI: 10.1111/1346-8138.17017</identifier><identifier>PMID: 37950501</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>Antibodies, Monoclonal - therapeutic use ; Antibodies, Monoclonal, Humanized - therapeutic use ; Atopic dermatitis ; Dermatitis, Atopic - drug therapy ; Double-Blind Method ; Humans ; Letter to the Editor ; Letters to the Editor ; Monoclonal antibodies ; Retrospective Studies ; Severity of Illness Index ; Treatment Outcome</subject><ispartof>Journal of dermatology, 2024-03, Vol.51 (3), p.e63-e65</ispartof><rights>2023 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Dermatological Association.</rights><rights>2023. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c4227-91ecb9b43d34b2988628a122a2802b23c16807945878dfcf27f72c40029626e73</cites><orcidid>0000-0002-0296-9996 ; 0000-0003-4443-4161 ; 0000-0002-7295-5725</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2F1346-8138.17017$$EPDF$$P50$$Gwiley$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2F1346-8138.17017$$EHTML$$P50$$Gwiley$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37950501$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kang, Da‐Hyun</creatorcontrib><creatorcontrib>Kwon, Soon‐Hyo</creatorcontrib><creatorcontrib>Lew, Bark‐Lynn</creatorcontrib><title>Four‐year long‐term drug survival of dupilumab analyzed by treatment period in patients with moderate to severe atopic dermatitis: A real‐world retrospective study</title><title>Journal of dermatology</title><addtitle>J Dermatol</addtitle><subject>Antibodies, Monoclonal - therapeutic use</subject><subject>Antibodies, Monoclonal, Humanized - therapeutic use</subject><subject>Atopic dermatitis</subject><subject>Dermatitis, Atopic - drug therapy</subject><subject>Double-Blind Method</subject><subject>Humans</subject><subject>Letter to the Editor</subject><subject>Letters to the Editor</subject><subject>Monoclonal antibodies</subject><subject>Retrospective Studies</subject><subject>Severity of Illness Index</subject><subject>Treatment Outcome</subject><issn>0385-2407</issn><issn>1346-8138</issn><issn>1346-8138</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>EIF</sourceid><recordid>eNqFkstu1DAUhiMEotPCmh2yxIZNWt8SO2xQVVouqsQG1pYTn0xdOXGwnRmFFY_Q1-C1eBI8TBkBG7yxffz5t8_5T1E8I_iU5HFGGK9LSZg8JQIT8aBYHSIPixVmsiopx-KoOI7xFmPaVAQ_Lo6YaCpcYbIqvl_5Ofz4dreADsj5cZ3XCcKATJjXKM5hYzfaId8jM0_WzYNukR61W76CQe2CUgCdBhgTmiBYb5Ad0aSTzZGItjbdoMEbCDoBSh5F2EAApJOfbIdyfMhosvEVOkdZyOXHtz44kzcp-DhBl-wGUEyzWZ4Uj3rtIjy9n0-Kz1eXny7eldcf376_OL8uO06pKBsCXdu0nBnGW9pIWVOpCaWaSkxbyjpSSywaXkkhTd_1VPSCdnxXm5rWINhJ8XqvO83tAKbLmQTt1BTsoMOivLbq75PR3qi13yhCuGS0wVnh5b1C8F9miEkNNnbgnB7Bz1FRKRvKWV2RjL74B73NfuT6ZqphnAhOcZWpsz3V5aLEAP3hNwSrXR-onetq57r61Qf5xvM_kzjwv43PQLUHttbB8j899eHN5V74J8igwyU</recordid><startdate>202403</startdate><enddate>202403</enddate><creator>Kang, Da‐Hyun</creator><creator>Kwon, Soon‐Hyo</creator><creator>Lew, Bark‐Lynn</creator><general>Wiley Subscription Services, Inc</general><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-0296-9996</orcidid><orcidid>https://orcid.org/0000-0003-4443-4161</orcidid><orcidid>https://orcid.org/0000-0002-7295-5725</orcidid></search><sort><creationdate>202403</creationdate><title>Four‐year long‐term drug survival of dupilumab analyzed by treatment period in patients with moderate to severe atopic dermatitis: A real‐world retrospective study</title><author>Kang, Da‐Hyun ; Kwon, Soon‐Hyo ; Lew, Bark‐Lynn</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4227-91ecb9b43d34b2988628a122a2802b23c16807945878dfcf27f72c40029626e73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Antibodies, Monoclonal - therapeutic use</topic><topic>Antibodies, Monoclonal, Humanized - therapeutic use</topic><topic>Atopic dermatitis</topic><topic>Dermatitis, Atopic - drug therapy</topic><topic>Double-Blind Method</topic><topic>Humans</topic><topic>Letter to the Editor</topic><topic>Letters to the Editor</topic><topic>Monoclonal antibodies</topic><topic>Retrospective Studies</topic><topic>Severity of Illness Index</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kang, Da‐Hyun</creatorcontrib><creatorcontrib>Kwon, Soon‐Hyo</creatorcontrib><creatorcontrib>Lew, Bark‐Lynn</creatorcontrib><collection>Wiley Online Library Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kang, Da‐Hyun</au><au>Kwon, Soon‐Hyo</au><au>Lew, Bark‐Lynn</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Four‐year long‐term drug survival of dupilumab analyzed by treatment period in patients with moderate to severe atopic dermatitis: A real‐world retrospective study</atitle><jtitle>Journal of dermatology</jtitle><addtitle>J Dermatol</addtitle><date>2024-03</date><risdate>2024</risdate><volume>51</volume><issue>3</issue><spage>e63</spage><epage>e65</epage><pages>e63-e65</pages><issn>0385-2407</issn><issn>1346-8138</issn><eissn>1346-8138</eissn><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>37950501</pmid><doi>10.1111/1346-8138.17017</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0002-0296-9996</orcidid><orcidid>https://orcid.org/0000-0003-4443-4161</orcidid><orcidid>https://orcid.org/0000-0002-7295-5725</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0385-2407 |
| ispartof | Journal of dermatology, 2024-03, Vol.51 (3), p.e63-e65 |
| issn | 0385-2407 1346-8138 1346-8138 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11483290 |
| source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
| subjects | Antibodies, Monoclonal - therapeutic use Antibodies, Monoclonal, Humanized - therapeutic use Atopic dermatitis Dermatitis, Atopic - drug therapy Double-Blind Method Humans Letter to the Editor Letters to the Editor Monoclonal antibodies Retrospective Studies Severity of Illness Index Treatment Outcome |
| title | Four‐year long‐term drug survival of dupilumab analyzed by treatment period in patients with moderate to severe atopic dermatitis: A real‐world retrospective study |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T09%3A10%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Four%E2%80%90year%20long%E2%80%90term%20drug%20survival%20of%20dupilumab%20analyzed%20by%20treatment%20period%20in%20patients%20with%20moderate%20to%20severe%20atopic%20dermatitis:%20A%20real%E2%80%90world%20retrospective%20study&rft.jtitle=Journal%20of%20dermatology&rft.au=Kang,%20Da%E2%80%90Hyun&rft.date=2024-03&rft.volume=51&rft.issue=3&rft.spage=e63&rft.epage=e65&rft.pages=e63-e65&rft.issn=0385-2407&rft.eissn=1346-8138&rft_id=info:doi/10.1111/1346-8138.17017&rft_dat=%3Cproquest_pubme%3E2889243651%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2934174205&rft_id=info:pmid/37950501&rfr_iscdi=true |